Added to YB: 2024-12-05
Pitch date: 2024-12-04
IXI.L [bullish]
IXICO plc
+13.95%
current return
Author Info
No bio for this author
Company Info
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.
Market Cap
GBP 13.0M
Pitch Price
GBP 0.11
Price Target
24.00 (+19492%)
Dividend
N/A
EV/EBITDA
-6.78
P/E
-6.09
EV/Sales
1.28
Sector
Life Sciences Tools and Services
Category
growth
IXICO plc (IXI.L): AI-Powered Neuroscience Imaging Sees Strong Growth and Margin Expansion
IXI.L: AI-powered medical imaging for neuroscience drug trials. H2 revenue +27% to £3.3m, orderbook +20% to £15.3m. Gross margins up 40% to 51%. Forecasts: FY'25 £6.0m revenue, -£1.4m EBITDA, £3m net cash. 1.4x EV/sales vs peers 3.0-3.5x. Cavendish 24p target. CEO confident in growth from AI platform, innovation, global expansion.
Read full article (2 min)